Atlas Trials

Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes

Clinical trial NCT00103935 · COMPLETED

Trial details

NCT number
NCT00103935
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2005-02-01
Primary completion
2005-10-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.